{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:41Z","timestamp":1790996801078,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"TechnoPhage S.A."},{"DOI":"10.13039\/100013297","name":"Eurostars","doi-asserted-by":"publisher","award":["ES#5553"],"award-info":[{"award-number":["ES#5553"]}],"id":[{"id":"10.13039\/100013297","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EUREKA"},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.pbb.2019.172828","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T19:38:39Z","timestamp":1574883519000},"page":"172828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Identification of antiparkinsonian drugs in the 6-hydroxydopamine zebrafish model"],"prefix":"10.1016","volume":"189","author":[{"given":"Rita L.","family":"Vaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Chapela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herma C.","family":"van der Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana D.","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago F.","family":"Outeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno D.","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2019.172828_bb0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1471-4159.2004.02190.x","article-title":"Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"88","author":"Anichtchik","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2019.172828_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tins.2010.11.001","article-title":"Repairing the parkinsonian brain with neurotrophic factors","volume":"34","author":"Aron","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pbb.2019.172828_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","article-title":"The ongoing pursuit of neuroprotective therapies in Parkinson disease","volume":"11","author":"Athauda","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pbb.2019.172828_bb0020","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/pmic.201500291","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson\u2019s disease in zebrafish","volume":"16","author":"Babu","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.pbb.2019.172828_bb0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.expneurol.2004.03.005","article-title":"Neuroprotective effect of rasagiline in a rodent model of Parkinson\u2019s disease","volume":"187","author":"Blandini","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2019.172828_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2010.04.014","article-title":"Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects","volume":"59","author":"Buckley","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2019.172828_bb0035","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1242\/jeb.203.17.2565","article-title":"Locomotor repertoire of the larval zebrafish: swimming, turning and prey capture","volume":"203","author":"Budick","year":"2000","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.pbb.2019.172828_bb0040","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u201cRejuvenation\u201d protects neurons in mouse models of Parkinson\u2019s disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2019.172828_bb0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2013.02.069","article-title":"Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish","volume":"543","author":"Chong","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2019.172828_bb0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuroscience.2017.10.018","article-title":"Neuroprotective and Neuro-restorative effects of minocycline and Rasagiline in a Zebrafish 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"367","author":"Cronin","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2019.172828_bb0055","first-page":"404","article-title":"Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?","volume":"33","author":"Davies","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.pbb.2019.172828_bb0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2019.172828_bb0065","first-page":"1","article-title":"Spatial and temporal distribution of dopaminergic neurons during development in zebrafish","volume":"10","author":"Du","year":"2016"},{"key":"10.1016\/j.pbb.2019.172828_bb0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ntt.2012.03.002","article-title":"Locomotor activity assay in zebrafish larvae: influence of age, strain and ethanol","volume":"34","author":"Esch","year":"2012","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pbb.2019.172828_bb0075","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.26048","article-title":"Norepinephrine deficiency in Parkinson\u2019s disease: the case for noradrenergic enhancement","volume":"29","author":"Espay","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2019.172828_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nbd.2011.05.016","article-title":"Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of parkinsonism phenotypes in zebrafish models","volume":"44","author":"Farrell","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2019.172828_bb0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/zeb.2013.0950","article-title":"Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae","volume":"11","author":"Feng","year":"2014","journal-title":"Zebrafish"},{"key":"10.1016\/j.pbb.2019.172828_bb0090","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1471-4159.2008.05463.x","article-title":"Zebrafish as a new animal model for movement disorders","volume":"106","author":"Flinn","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2019.172828_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1242\/dmm.008383","article-title":"Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease","volume":"5","author":"Friedrich","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.pbb.2019.172828_bb0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/jnc.13214","article-title":"Chemogenetic ablation of dopaminergic neurons leads to transient locomotor impairments in zebrafish larvae","volume":"135","author":"Godoy","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2019.172828_bb0105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ecoenv.2005.07.006","article-title":"Comparative embryotoxicity and proteotoxicity of three carrier solvents to zebrafish (Danio rerio) embryos","volume":"63","author":"Hallare","year":"2006","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.pbb.2019.172828_bb0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mds.25032","article-title":"Pathogenesis of Parkinson\u2019s disease","volume":"28","author":"Hirsch","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2019.172828_bb0115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","article-title":"The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease","volume":"43","author":"Ilijic","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2019.172828_bb0120","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.pbb.2012.12.010","article-title":"Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish","volume":"103","author":"Irons","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.172828_bb0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.brainresbull.2007.10.043","article-title":"Functional and developmental analysis of the blood-brain barrier in zebrafish","volume":"75","author":"Jeong","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2019.172828_bb0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/zeb.2012.0861","article-title":"Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond","volume":"10","author":"Kalueff","year":"2013","journal-title":"Zebrafish"},{"key":"10.1016\/j.pbb.2019.172828_bb0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/cne.22214","article-title":"Genetic dissection of dopaminergic and noradrenergic contributions to catecholaminergic tracts in early larval zebrafish","volume":"518","author":"Kastenhuber","year":"2010","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pbb.2019.172828_bb0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2005.02.002","article-title":"Pharmacological validation of a mouse model of L-DOPA-induced dyskinesia","volume":"194","author":"Lundblad","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2019.172828_bb0145","first-page":"1","article-title":"Current and experimental treatments of Parkinson disease: a guide for neuroscientists","author":"Oertel","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2019.172828_bb0150","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A double-blind, delayed-start trial of Rasagiline in Parkinson\u2019s disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbb.2019.172828_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2010.05.010","article-title":"The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases","volume":"40","author":"Panula","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2019.172828_bb0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ntt.2006.04.003","article-title":"A zebrafish assay for identifying neuroprotectants in vivo","volume":"28","author":"Parng","year":"2006","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pbb.2019.172828_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40120-013-0014-1","article-title":"Rasagiline and rapid symptomatic motor effect in Parkinson's disease: review of literature","volume":"3","author":"Pistacchi","year":"2014","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.pbb.2019.172828_bb0170","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/jnr.22685","article-title":"Brain-derived neurotrophic factor modulates antiretroviral-induced mechanical allodynia in the mouse","volume":"89","author":"Renn","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pbb.2019.172828_bb0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cbpa.2014.10.025","article-title":"15 years of Zebrafish chemical screening","volume":"24","author":"Rennekamp","year":"2015","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.pbb.2019.172828_bb0180","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ntt.2011.07.007","article-title":"Zebrafish neurotransmitter systems as potential pharmacological and toxicological targets","volume":"33","author":"Rico","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pbb.2019.172828_bb0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0006-8993(00)03174-7","article-title":"The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum)","volume":"889","author":"Rink","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2019.172828_bb0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0361-9230(01)00696-7","article-title":"Connections of the ventral telencephalon and tyrosine hydroxylase distribution in the zebrafish brain (Danio rerio) lead to identification of an ascending dopaminergic system in a teleost","volume":"57","author":"Rink","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2019.172828_bb0195","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1242\/dmm.024935","article-title":"Identification of benzopyrone as a common structural feature in compounds with anti-inflammatory activity in a zebrafish phenotypic screen","volume":"9","author":"Robertson","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.pbb.2019.172828_bb0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.108.150425","article-title":"Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling","volume":"330","author":"Rylander","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2019.172828_bb0205","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.tips.2006.08.002","article-title":"Opioids and motor complications in Parkinson\u2019s disease","volume":"27","author":"Samadi","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2019.172828_bb0210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.pbb.2019.172828_bb0215","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biopsych.2008.09.008","article-title":"Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-Dihydroxyphenylalanine-induced dyskinesia","volume":"65","author":"Schuster","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.172828_bb0220","first-page":"1","article-title":"Zebrafish chemical screening reveals the impairment of dopaminergic neuronal survival by cardiac glycosides","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2019.172828_bb0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ncomms1171","article-title":"Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems","volume":"2","author":"Tay","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbb.2019.172828_bb0230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.107.126052","article-title":"(\u2212)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (Tapentadol HCl): a novel u-opioid receptor agonist\/norepinephrine reuptake inhibitor with broad-Spectrum analgesic properties","volume":"323","author":"Tzschentke","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2019.172828_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00347","article-title":"Zebrafish as an animal model for drug discovery in Parkinson\u2019s disease and other movement disorders: a systematic review","volume":"9","author":"Vaz","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pbb.2019.172828_bb0240","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s40265-016-0566-3","article-title":"Drug-induced dyskinesia, part 1: treatment of levodopa-induced dyskinesia","volume":"76","author":"Vijayakumar","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.pbb.2019.172828_bb0245","first-page":"1","article-title":"6-OHDA-Lesioned adult zebrafish as a useful Parkinson\u2019s disease model for dopaminergic neuroregeneration","author":"Vijayanathan","year":"2017","journal-title":"Neurotox. Res. Epub ahead"},{"key":"10.1016\/j.pbb.2019.172828_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-8546-6-16","article-title":"Eriocaulon buergerianum extract protects PC12 cells and neurons in zebrafish against 6-hydroxydopamine-induced damage","volume":"6","author":"Wang","year":"2011","journal-title":"Chin. Med."},{"key":"10.1016\/j.pbb.2019.172828_bb0255","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuro.2016.11.006","article-title":"Parkinson\u2019s disease-like motor and non-motor symptoms in rotenone-treated zebrafish","volume":"58","author":"Wang","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pbb.2019.172828_bb0260","series-title":"The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio)","author":"Westerfield","year":"2000"},{"key":"10.1016\/j.pbb.2019.172828_bb0265","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11910-011-0182-2","article-title":"Modeling neurodegeneration in zebrafish","volume":"11","author":"Xi","year":"2011","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.pbb.2019.172828_bb0270","first-page":"195","article-title":"Quercetin exerts a neuroprotective effect through inhibition of the iNOS\/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish","volume":"27","author":"Zhang","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.pbb.2019.172828_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10571-011-9731-0","article-title":"Ethanolic extract of fructus alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish","volume":"32","author":"Zhang","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2019.172828_bb0280","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jphysparis.2008.10.007","article-title":"Adult neurogenesis and neuronal regeneration in the brain of teleost fish","volume":"102","author":"Zupanc","year":"2008","journal-title":"J. Physiol. Paris"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571930156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571930156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:35:56Z","timestamp":1758774956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009130571930156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":56,"alternative-id":["S009130571930156X"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2019.172828","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of antiparkinsonian drugs in the 6-hydroxydopamine zebrafish model","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2019.172828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"172828"}}